Mesa Laboratories, Inc. (MLAB) EPS Estimated At $1.93

May 17, 2018 - By Jason Grubb

Mesa Laboratories, Inc. (NASDAQ:MLAB) LogoInvestors sentiment decreased to 1.21 in 2017 Q4. Its down 0.67, from 1.88 in 2017Q3. It turned negative, as 12 investors sold Mesa Laboratories, Inc. shares while 26 reduced holdings. 9 funds opened positions while 37 raised stakes. 2.66 million shares or 6.81% more from 2.49 million shares in 2017Q3 were reported.
Legal General Public Ltd Com invested in 807 shares. 87,142 are owned by Kayne Anderson Rudnick Invest Mngmt Ltd Liability. 28,679 are owned by Geode Management Lc. Wells Fargo Company Mn reported 0% in Mesa Laboratories, Inc. (NASDAQ:MLAB). Envestnet Asset Mngmt invested 0% in Mesa Laboratories, Inc. (NASDAQ:MLAB). Kistler holds 0.12% of its portfolio in Mesa Laboratories, Inc. (NASDAQ:MLAB) for 2,444 shares. 3,012 are owned by Credit Suisse Ag. Bancshares Of Montreal Can reported 17 shares or 0% of all its holdings. Barclays Public Ltd Company, United Kingdom-based fund reported 515 shares. Bnp Paribas Arbitrage reported 0% of its portfolio in Mesa Laboratories, Inc. (NASDAQ:MLAB). Us Comml Bank De invested 0% in Mesa Laboratories, Inc. (NASDAQ:MLAB). Fifth Third State Bank, a Ohio-based fund reported 9 shares. Great West Life Assurance Can, Manitoba – Canada-based fund reported 400 shares. Bancorporation Of New York Mellon invested in 0% or 17,234 shares. Lord Abbett & Commerce reported 23,379 shares stake.

Since February 15, 2018, it had 0 insider buys, and 2 selling transactions for $1.27 million activity. Sullivan John James also sold $552,000 worth of Mesa Laboratories, Inc. (NASDAQ:MLAB) shares.

Analysts expect Mesa Laboratories, Inc. (NASDAQ:MLAB) to report $1.93 EPS on June, 6.They anticipate $0.69 EPS change or 55.65 % from last quarter’s $1.24 EPS. MLAB’s profit would be $7.30 million giving it 21.76 P/E if the $1.93 EPS is correct. After having $-0.24 EPS previously, Mesa Laboratories, Inc.’s analysts see -904.17 % EPS growth. The stock decreased 1.06% or $1.8 during the last trading session, reaching $168. About 10,693 shares traded. Mesa Laboratories, Inc. (NASDAQ:MLAB) has risen 13.08% since May 17, 2017 and is uptrending. It has outperformed by 1.53% the S&P500.

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products. The company has market cap of $635.57 million. The company??s Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness. It currently has negative earnings. This segment??s products are used in healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, environmental air sampling, and semiconductor industries.

Mesa Laboratories, Inc. (NASDAQ:MLAB) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.